CPSI Biotech has developed a widely applicable product, technology and intellectual property portfolio spanning the Biotech and MedTech spaces designed for use in the clinical and life science research arenas. Our active product pipeline currently includes more than 10 prototype devices (machines, probes and formulations) in various developmental stages.
Focus areas for CPSI include medical device development for the treatment of various cancers and cardiovascular diseases, as well as the development of new life science technologies for use in the biotech (research and cell therapy) fields.
CPSI’s investigative approaches are based on a unique integrated engineering and life sciences strategy designed to identify and modulate stress pathways activated in cells and tissues exposed to stressful environments and the utilization of this information as the foundation for the development of new technologies, processes, and protocols. Employing this strategy, CPSI has developed a unique and diverse portfolio of new technologies encompassing many potential application areas.
DISCLAIMER: CPSI BIOTECH’S TECHNOLOGIES ARE CURRENTLY INVESTIGATIONAL DEVICES AND ARE LIMITED BY FEDERAL LAW TO INVESTIGATIONAL USE ONLY.